The Patent Finder

Lotus Pharmaceutical Co., Ltd.

Also on record
Records under this name other than patents Lotus Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Lotus Pharmaceutical Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,088,818Catechol-Based Derivatives for Treating or Preventing Diabetics
Formerly held
Term ended
Term ended Sep 3, 2026 · Medium confidence
Term endedTerm ended Sep 3, 2026Medium confidence
US 7,045,516Benzoxazole Derivatives and Medicaments Comprising Said Derivatives as Active Ingredient
Lapsed on the fee record
Ended May 16, 2018 · High confidence
Lapsed on the fee recordEnded May 16, 2018High confidence
US 7,655,255Topical composition for transdermal administration
Formerly held
Lapsed on the fee record
Ended Feb 2, 2018 · USPTO record
Lapsed on the fee recordEnded Feb 2, 2018USPTO record
US 6,037,342Serotonin 5-HT.sub.3 receptor partial activator
Term ended
Term ended May 6, 2017 · USPTO record
Term endedTerm ended May 6, 2017USPTO record
US 6,867,226Serotonin 5-HT3 receptor partial activator
Lapsed on the fee record
Ended Mar 15, 2017 · USPTO record
Lapsed on the fee recordEnded Mar 15, 2017USPTO record
US 6,552,057Serotonin 5-HT3 receptor partial activator
Lapsed on the fee record
Ended Apr 22, 2015 · USPTO record
Lapsed on the fee recordEnded Apr 22, 2015USPTO record
US 7,057,044Aporphine and oxoaporphine compounds and pharmaceutical use thereof
Lapsed on the fee record
Ended Jun 6, 2014 · USPTO record
Lapsed on the fee recordEnded Jun 6, 2014USPTO record
US 6,333,328Serotonin 5-HT3 receptor partial activator
Lapsed on the fee record
Ended Dec 25, 2013 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2013USPTO record
US 6,297,246Serotonin 5-HT3, receptor partial activator
Lapsed on the fee record
Ended Oct 2, 2013 · USPTO record
Lapsed on the fee recordEnded Oct 2, 2013USPTO record
US 7,294,715Aporphine and oxoaporphine compounds and pharmaceutical use thereof
Lapsed on the fee record
Ended Nov 13, 2011 · USPTO record
Lapsed on the fee recordEnded Nov 13, 2011USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited